In the social media world, hashtags are ubiquitously used by the general public, marketers and their agencies.
Last week, the United States Patent and Trademark Office (“USPTO”) in Lee v. Simon Shiao Tam, asked the United States Supreme Court to reverse the decision of the United States Federal Circuit, which held that trademark law’s ban on “disparaging” trademark registrations violates the First Amendment.
The Fourth Circuit hasn’t ruled yet, but the D.C. NFL team is already appealing to the Supreme Court in order to hop on a similar case. Which is fair, since they’ve been two sides of the same coin for their entire duration.
The owners of the Washington Redskins NFL team have petitioned the U.S. Supreme Court to hear their trademark cancellation appeal, even though the Fourth Circuit has yet to rule on the team’s case.
Question for the day, how common is the given name Elle? I’m really not sure, I don’t believe I’ve ever personally known anyone with that name, and Mongabay doesn’t even include Elle in its listing of girl’s first names, but it does rank Ella (210), Elena (412), Ellie (1198), Elly (2802), and Ellamae (3514) among the top female first names in America.
On April 20, 2016, the United States Patent and Trademark Office (“PTO”) filed a petition for a writ of certiorari to the Federal Circuit seeking Supreme Court review of that Court’s decision in In re Tam, 117 USPQ2d 1001 (Fed. Cir. 2016), holding the disparagement provision of Section 2(a) of the Lanham Act, 15 USC §1052(a), to be facially unconstitutional as a violation of the Free Speech Clause of the First Amendment.
On Wednesday, April 20, 2016, the United States Patent and Trademark Office petitioned the Supreme Court to take up the case on disparaging trademarks.
New Rules for AIA Review Proceedings Intended to Provide More Federal Court Style PTAB Trial Practice
The U.S. Patent and Trademark Office (“PTO”) this week published its highly anticipated Notice of Amendments to the Rules of Practice for Trials Before the Patent Trial and Appeal Board (“PTAB”).
The U.S. Patent and Trademark Office (“PTO”) issued amendments to its “Rules of Practice for Trials before the Patent Trial and Appeal Board” for IPR, CBM, and PGR proceedings, which will be effective in all current and future proceedings starting on May 2, 2016.
The USPTO Patent Trial and Appeal Board (PTAB) decided not to institute inter partes review (IPR) of key claims of Jazz’s U.S. Patent 8,772,306, which is listed in the Orange Book for Xyrem®.